tykhr
sign in
free sign up
Citius Oncology, Inc.
Drug Manufacturers - Specialty & Generic
Healthcare
CTOR
71.55 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.90
52 week high
5.29
high
2.05
52 week low
0.00
low
1.81
growth
33.09 %
previous Close
1.78
P/E ratio
market cap
135 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-5.37 M
30.58 %
eps
0.00 %
27.27 %
eps surprise
46.67 %
net profit margin
-536995600.00 %
0.00 %
operating incoming
-4.94 M
33.81 %
net change in cash
0.00 %
cash on hand
112
0.00 %
cost of revenue
0.00 %
top